8th Annual Pricing, Reimbursement & Market Access in Pharma 2013

Key Topics

• The concept of risk-sharing to accelerate the market access
• Developing an effective strategy to succeed in country-specific negotiations for price approval and granting of reimbursement
• Dealing with the increasing complexity and uncertainty in current pricing & reimbursement environment
• Critical insights into HTAs & their role in assessments of new drugs
• Make market access an integral part of the company & incorporate market access into the entire drug’s life cycle
• Cost-effectiveness measures & the impact on the industry
• The role of HTAs
• How can interaction between regulators and payers facilitate access to orphan drugs?

The 8th Annual Pricing, Reimbursement & Market Access in Pharma 2013 brings together Vice Presidents, Senior Vice Presidents, Global Heads, Senior Executives, Directors, Heads, Managers and Senior Managers of: Reimbursement, Pricing, Commercial Pricing Pricing Strategists, Market Access, Outcomes Research, Health Economics, Governmental Affairs, Regulatory Affairs, Public Policy Directors, Public Affairs, Governmental bodies, Operations and Regulatory bodies.